Table 3.
Correlation assessment between primary outcome and key blood parameters and platelet and growth factor properties in samples of platelet rich plasma
Key blood parameters and platelet properties | No | r | Variance (%)* | P value |
---|---|---|---|---|
Blood cell counts | ||||
Erythrocyte count | 91 | 0.13 | 1.59 | 0.23 |
Leucocyte count | 91 | −0.10 | 1.05 | 0.33 |
Platelet count† | 88 | 0.13 | 1.65 | 0.23 |
Platelet quality (resting) | ||||
Resting CD62p expression (%) | 93 | 0.10 | 0.92 | 0.75 |
Mean fluorescence intensity | 94 | −0.03 | 0.07 | 0.97 |
Platelet quality (activated) | ||||
Activated CD62p expression (%) | 92 | 0.04 | 0.14 | 0.72 |
Mean fluorescence intensity | 92 | <−0.01 | <0.01 | 0.97 |
Growth factors | ||||
Insulin-like growth factor 1 | 93 | 0.12 | 1.25 | 0.29 |
Transforming growth factor β1 | 88 | 0.01 | <0.01 | 0.96 |
Platelet derived growth factor-AB | 90 | <0.01 | <0.01 | 1.00 |
Vascular endothelial growth factor | 93 | −0.23 | 5.35 | 0.03 |
Fibroblast growth factor-basic | 93 | −0.10 | 1.05 | 0.33 |
CD62p=P selectin.
Proportion of variance in work limb symmetry index explained by blood parameter.
As fluorescent platelet count.